Pregnancy and heart disease: Pregnancy in congenital and valvular heart disease

Heart

Volumn 97, Issue 21, 2011, Pages 1803-1809

  Kaleschke, Gerrit ^a   Baumgartner, Helmut ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BLOOD CLOTTING FACTOR 11A; DIGOXIN; DIURETIC AGENT; FLECAINIDE; FUROSEMIDE; HEPARIN; HYDRALAZINE; LOW MOLECULAR WEIGHT HEPARIN; METHYLDOPA; METOPROLOL; PHENPROCOUMON; SODIUM CHANNEL BLOCKING AGENT; THIAZIDE DIURETIC AGENT; VERAPAMIL;

AORTA DISEASE; AORTA OCCLUSION; AORTA STENOSIS; AORTA VALVE REGURGITATION; AORTIC VALVE REPAIR; BLEEDING; BLOOD VOLUME; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CESAREAN SECTION; CONGENITAL HEART DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; DRUG EFFECT; ECHOCARDIOGRAPHY; EISENMENGER COMPLEX; EMBRYOPATHY; EXERCISE TEST; FETUS WASTAGE; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART DISEASE; HEART FAILURE; HEART HEMODYNAMICS; HEART OUTPUT; HEART RIGHT VENTRICLE FUNCTION; HEMOSTASIS; HIGH RISK PREGNANCY; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; HYPERVOLEMIA; INTERVENTION STUDY; IRON THERAPY; LOW DRUG DOSE; MATERNAL MORTALITY; MEDICAL HISTORY; MITRAL VALVE REGURGITATION; OBESITY; PATIENT COUNSELING; PREGNANCY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; PULSE OXIMETRY; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SCORING SYSTEM; SPONTANEOUS ABORTION; SUPRAVENTRICULAR TACHYCARDIA; THROMBOEMBOLISM; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VAGINAL DELIVERY; VALVULAR HEART DISEASE; VENOUS THROMBOEMBOLISM; VITAMIN SUPPLEMENTATION; ARTICLE; CONGENITAL HEART MALFORMATION; FEMALE; HEMODYNAMICS; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRENATAL CARE;

FEMALE; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; HEMODYNAMICS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PRENATAL CARE; RISK ASSESSMENT;

EID: 80053623827     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-300369     Document Type: Review

References (20)

1. CEMACH. CEMACH Saving Mothers' Lives: Reviewing Maternal Deaths To Make Motherhood Safer - 2003-2005: The Seventh Report On Confidential Enquiries Into Maternal Deaths in the United Kingdom. London: Centre for Maternal and Child Enquiries, 2008.
2. Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104:515-21. Important study including 599 pregnancies that identified prior cardiac events, poor functional class, cyanosis, left heart obstruction, and left ventricular dysfunction as independent risk factors for maternal cardiac complications (CARPREG score).
3. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borgh C, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J. Published Online First August 2011. [Epub ahead of print]. First ESC guidelines on this topic, delivering comprehensive general considerations and specific sections for each disease based on current scientific knowledge and replacing the expert consensus document of 2003.
4. Baumgartner H, Bonhoeffer P, De Groot NMS, et al. ESC guidelines for the management of grown-up congenital heart disease (new version 2010): the task force on the management of grown-up congenital heart disease of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2915-57. Most recent guidelines in grown-up congenital heart disease (GUCH), implementing recommendations for congenital heart disease in terms of diagnostic workup and indications for treatment of specific lesions. The document also includes general considerations about pregnancy and congenital heart disease as well as specific considerations for the different defects.
5. Drenthen W, Boersma E, Balci A, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 2010;31:2124-32. Recent ZAHARA study including 1302 pregnancies in women with congenital heart disease that identified cyanotic heart disease, use of cardiac medication, left heart obstruction, mechanical valve replacement, and systemic or pulmonary atrioventricular valve regurgitation as risk factors for maternal cardiac events. The authors suggest a new risk score that still has to be prospectively evaluated. One major limitation of the study is the lack of information on ventricular function.
6. Manalo-Estrella P, Barker AE. Histopathologic findings in human aortic media associated with pregnancy. Arch Pathol 1967;83:336-41.
7. Anderson GD. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 2005;44:989-1008. (Pubitemid 41356388)
8. Siu SC, Colman JM, Sorensen S, et al. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 2002;105:2179-84. (Pubitemid 34517162)
9. Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart 2006;92:1520-5. (Pubitemid 44578860)
10. Bedard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J 2009;30:256-65.
11. Weiss BM, Zemp L, Seifert B, et al. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol 1998;31:1650-7. Report of 96 pregnancies in 44 patients with cyanotic heart disease (excluding Eisenmenger syndrome) describing a high incidence of maternal cardiovascular complications (32%) and only 43% live births.
12. Presbitero P, Somerville J, Stone S, et al. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation 1994;89:2673-6. (Pubitemid 24173686)
13. Avila WS, Grinberg M, Snitcowsky R, et al. Maternal and fetal outcome in pregnant women with Eisenmenger's syndrome. Eur Heart J 1995;16:460-4.
14. Jastrow N, Meyer P, Khairy P, et al. Prediction of complications in pregnant women with cardiac diseases referred to a tertiary center. Int J Cardiol 2011;151:209-13.
15. Khairy P, Ouyang DW, Fernandes SM, et al. Pregnancy outcomes in women with congenital heart disease. Circulation 2006;113:517-24.
16. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;52:e1-121.
17. Becker RM. Intracardiac surgery in pregnant women. Ann Thorac Surg 1983;36:453-8. (Pubitemid 13015005)
18. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000;160:191-6. (Pubitemid 30054338)
19. Abildgaard U, Sandset PM, Hammerstrom J, et al. Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin. Thromb Res 2009;124:262-7.
20. Sillesen M, Hjortdal V, Vejlstrup N, et al. Pregnancy with prosthetic heart valves - 30 years' nationwide experience in Denmark. Eur J Cardiothorac Surg 2011;40:448-54.